This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Arora U., Kedia S., Garg S., Bopanna S., Jain S., Yadav D.P., Goyal S., Gupta V., Sahni P., Pal S., Dash N.R., Madhusudhan K.S., Sharma R., Makharia G., Ahuja V.: Colonic Crohn’s disease is associated with less aggressive disease course than ileal or ileocolonic disease. Dig. Dis. Sci., 2018; 63: 1592–1599AroraU.KediaS.GargS.BopannaS.JainS.YadavD.P.GoyalS.GuptaV.SahniP.PalS.DashN.R.MadhusudhanK.S.SharmaR.MakhariaG.AhujaV.Colonic Crohn’s disease is associated with less aggressive disease course than ileal or ileocolonic disease2018631592159910.1007/s10620-018-5041-4Search in Google Scholar
Bartnik W.: Choroba Crohna jelita grubego. Pol. Arch. Med. Wewn., 1971; 47: 383–388BartnikW.Choroba Crohna jelita grubego197147383388Search in Google Scholar
Bartnik W.: Inflammatory bowel disease – polish contribution. J. Physiol. Pharmacol. 2003; 54 Suppl., 3: 205–210BartnikW.Inflammatory bowel disease – polish contribution200354Suppl. 3205210Search in Google Scholar
Cleynen I., Boucher G., Jostins L., Schumm P., Zeissig S., Ahmad T., Andersen V., Andrews J.M., Annese V., Brand S., Brant S.R., Cho J.C., Daly M.J., Dubinsky M., Duerr R.H., et al.: International Inflammatory Bowel Disease Genetics Consortium. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: A genetic association study. Lancet, 2016; 387: 156–167CleynenI.BoucherG.JostinsL.SchummP.ZeissigS.AhmadT.AndersenV.AndrewsJ.M.AnneseV.BrandS.BrantS.R.ChoJ.C.DalyM.J.DubinskyM.DuerrR.H.International Inflammatory Bowel Disease Genetics Consortium. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: A genetic association study201638715616710.1016/S0140-6736(15)00465-1Search in Google Scholar
Cleynen I., González J.R., Figueroa C., Franke A., McGovern D., Bortlík M., Crusius B.JA., Vecchi M., Artieda M., Szczypiorska M., Bethge J., Arteta D., Ayala E., Danese S., Hogezand R., et al.: Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBD European Project. Gut, 2013; 62: 1556–1565CleynenI.GonzálezJ.R.FigueroaC.FrankeA.McGovernD.BortlíkM.CrusiusB.JA.VecchiM.ArtiedaM.SzczypiorskaM.BethgeJ.ArtetaD.AyalaE.DaneseS.HogezandR.Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBD European Project2013621556156510.1136/gutjnl-2011-300777Search in Google Scholar
Crohn B.B., Ginzburg L., Oppenheimer G.D.: Regional ileitis; a pathologic and clinical entity. JAMA, 1932; 99; 1323–1329CrohnB.B.GinzburgL.OppenheimerG.D.Regional ileitis; a pathologic and clinical entity1932991323132910.1001/jama.1932.02740680019005Search in Google Scholar
Daperno M., D’Haens G., Van Assche G., Baert F., Bulois P., Maunoury V., Sostegni R., Rocca R., Pera A., Gevers A., Mary Y.V., Colombel J.F., Rutgeerts P.: Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD. Gastrointest. Endosc., 2004; 60: 505–512DapernoM.D’HaensG.Van AsscheG.BaertF.BuloisP.MaunouryV.SostegniR.RoccaR.PeraA.GeversA.MaryY.V.ColombelJ.F.RutgeertsP.Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD20046050551210.1016/S0016-5107(04)01878-4Search in Google Scholar
Dulai P.S., Singh S., Casteele N.V., Boland B.S., Rivera-Nieves J., Ernst P.B., Eckmann L., Barrett K.E., Chang J.T., Sandborn W.J.: Should we divide Crohn’s disease into ileum-dominant and isolated colonic diseases? Clin. Gastroenterol. Hepatol., 2019; 17: 2634–2643DulaiP.S.SinghS.CasteeleN.V.BolandB.S.Rivera-NievesJ.ErnstP.B.EckmannL.BarrettK.E.ChangJ.T.SandbornW.J.Should we divide Crohn’s disease into ileum-dominant and isolated colonic diseases?2019172634264310.1016/j.cgh.2019.04.040688545331009791Search in Google Scholar
Fiocchi C.: Inflammatory bowel disease pathogenesis: Where are we? J. Gastroenterol. Hepatol., 2015; 30, Suppl. 1: 12–28FiocchiC.Inflammatory bowel disease pathogenesis: Where are we?201530Suppl. 1122810.1111/jgh.1275125827798Search in Google Scholar
Guizzetti L., Zou G., Khanna R., Dulai P.S., Sandborn W.J., Jairath V., Feagan B.G.: Development of clinical prediction models for surgery and complications in Crohn’s disease. J. Crohns. Colitis, 2018; 12: 167–177GuizzettiL.ZouG.KhannaR.DulaiP.S.SandbornW.J.JairathV.FeaganB.G.Development of clinical prediction models for surgery and complications in Crohn’s disease20181216717710.1093/ecco-jcc/jjx130588174629028958Search in Google Scholar
Hancock L., Beckly J., Geremia A., Cooney R., Cummings F., Pathan S., Guo C., Warren B., Mortensen N., Ahmad T., Jewell D.: Clinical and molecular characteristics of isolated colonic Crohn’s disease. Inflamm. Bowel Dis., 2008; 14: 1667–1677HancockL.BecklyJ.GeremiaA.CooneyR.CummingsF.PathanS.GuoC.WarrenB.MortensenN.AhmadT.JewellD.Clinical and molecular characteristics of isolated colonic Crohn’s disease2008141667167710.1002/ibd.2051718521924Search in Google Scholar
Li D., Haritunians T., Landers C., Potdar A.P., Yang S., Huang H., Schumm P., Daly M., Targan S., McGovern D.: Late-onset Crohn’s disease is a subgroup distinct in genetic and behavioral risk factors with UC-like characteristics. Inflamm. Bowel Dis., 2018; 24: 2413–2422LiD.HarituniansT.LandersC.PotdarA.P.YangS.HuangH.SchummP.DalyM.TarganS.McGovernD.Late-onset Crohn’s disease is a subgroup distinct in genetic and behavioral risk factors with UC-like characteristics2018242413242210.1093/ibd/izy148619517529860388Search in Google Scholar
Lockhart-Mummery H.E., Morson B.C.: Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut, 1960; 1: 87–105Lockhart-MummeryH.E.MorsonB.C.Crohn’s disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis196018710510.1136/gut.1.2.87141321714417801Search in Google Scholar
Łodyga M., Eder P., Bartnik W., Gonciarz M., Kłopocka M., Linke K., Małecka-Panas E., Radwan P., Rydzewska G.: Guidelines for the management of Crohn’s disease. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology. Gastroenterology Rev., 2013; 7: 317–338ŁodygaM.EderP.BartnikW.GonciarzM.KłopockaM.LinkeK.Małecka-PanasE.RadwanP.RydzewskaG.Guidelines for the management of Crohn’s disease. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology2013731733810.5114/pg.2012.33040Search in Google Scholar
Mulder D.J., Noble A.J., Justinich C.J., Duffin J.M.: A tale of two diseases: The history of inflammatory bowel disease. J. Crohns Colitis, 2014; 8: 341–348MulderD.J.NobleA.J.JustinichC.J.DuffinJ.M.A tale of two diseases: The history of inflammatory bowel disease2014834134810.1016/j.crohns.2013.09.00924094598Search in Google Scholar
Parkes G.C., Whelan K., Lindsay J.O.: Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J. Crohns Colitis, 2014; 8: 717–725ParkesG.C.WhelanK.LindsayJ.O.Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect2014871772510.1016/j.crohns.2014.02.00224636140Search in Google Scholar
Sandborn W.J., Feagan B.G., Hanauer S.B., Lochs H., Löfberg R., Modigliani R., Present D.H., Rutgeerts P., Schölmerich J., Stange E.F., Sutherland L.R.: A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology, 2002; 122: 512–530SandbornW.J.FeaganB.G.HanauerS.B.LochsH.LöfbergR.ModiglianiR.PresentD.H.RutgeertsP.SchölmerichJ.StangeE.F.SutherlandL.R.A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease200212251253010.1053/gast.2002.3107211832465Search in Google Scholar
Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F.: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 2006; 55: 749–753SatsangiJ.SilverbergM.S.VermeireS.ColombelJ.F.The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications20065574975310.1136/gut.2005.082909185620816698746Search in Google Scholar
Solberg I.C., Cvancarova M., Vatn M.H., Moum B.: Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn’s disease. Inflamm. Bowel Dis., 2014; 20: 60–68SolbergI.C.CvancarovaM.VatnM.H.MoumB.Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn’s disease201420606810.1097/01.MIB.0000436956.78220.6724280875Search in Google Scholar
Solberg I.C., Vatn M.H., Hřie O., Stray N., Sauar J., Jahnsen J., Moum B., Lygren I.: Clinical course in Crohn’s disease: Results of a Norwegian population based ten-year follow-up study. Clin. Gastroenterol. Hepatol., 2007; 5: 1430–1438SolbergI.C.VatnM.H.HřieO.StrayN.SauarJ.JahnsenJ.MoumB.LygrenI.Clinical course in Crohn’s disease: Results of a Norwegian population based ten-year follow-up study200751430143810.1016/j.cgh.2007.09.00218054751Search in Google Scholar
Subramanian S., Ekbom A., Rhodes J.M.: Recent advances in clinical practice: A systematic review of isolated colonic Crohn’s disease: The third IBD? Gut, 2017; 66: 362–381SubramanianS.EkbomA.RhodesJ.M.Recent advances in clinical practice: A systematic review of isolated colonic Crohn’s disease: The third IBD?20176636238110.1136/gutjnl-2016-31267327802156Search in Google Scholar
Wells C.: Ulcerative colitis and Crohn’s disease. Ann. R. Coll. Surg. Engl., 1952; 11: 105–120WellsC.Ulcerative colitis and Crohn’s disease19521110512010.2307/585934Search in Google Scholar
Xu Y., Guo Z., Cao L., Xie T., Shen W., Li Y., Gong J., Zhu W.: Isolated colonic Crohn’s disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease. Clin. Nutr., 2019; 38: 1629–1635XuY.GuoZ.CaoL.XieT.ShenW.LiY.GongJ.ZhuW.Isolated colonic Crohn’s disease is associated with a reduced response to exclusive enteral nutrition compared to ileal or ileocolonic disease2019381629163510.1016/j.clnu.2018.08.02230193873Search in Google Scholar
Zhang Y.Z., Li Y.Y.: Inflammatory bowel disease: Pathogenesis. World J. Gastroenterol., 2014; 20: 91–99ZhangY.Z.LiY.Y.Inflammatory bowel disease: Pathogenesis201420919910.3748/wjg.v20.i1.91388603624415861Search in Google Scholar